Preisträger/in 2026

Award winners 2026

• 

  Elise Sophia Schneider – Hospital for radiooncologie, University of Freiburg

  Experience report EANO 2026:
  The EANO 2026 took place from 24th until 27th of September 2027 in Rome under the leadership of Prof. Guiseppe Minniti, a radiooncologist, bringing radiation oncology into the focus.
  It was a very good opportunity for me to experience a big conference and get to know great scientists.
  While the treatment of Glioblastoma was a huge topic, there were also discussions about radiation therapy and proton therapy.
  A highlight for me was the speech about the ROAM trail, presented by Prof. Michael Jenkinson, a neurosurgeon from Liverpool. The trail evaluated that early adjuvant radiation therapy after a complete resection of a phase 2 meningioma halves the recurrence rate compared to active surveillance. This was achieve without compromising patients´neurocognitive function or quality of live and underlining the efficacy of early radiation therapy.
  Furthermore the integration of artificial intelligence and advanced PET/MRI imaging was a discusses topic for automated target contouring and biologically guided dose painting.
  In the poster session on Saturday I could show my results and was able to get in touch with students and also young doctors. It was great to exchange and connect with people from different countries all interested in medicin, radioationtheraphy and science.
  To sum up, the congress was a great opportunity, highlighting a transition toward highly personalized multi-modal treatment that use both, systemic and radiotherapeutic interventions to each unique molecular profile.
  Thanks to DeGBS for making it possible for me to attend the congress and getting to see great achievements in neurooncology and experiencing my first big congress!

• 

  Christian Deglow – GSI Helmholtz Center for Heavy Ion Research GmbH, Biophysics Department, Radiobiological Modeling Group

  Experience report PTCOG 2026:
  Thanks to an international travel grant from DeGBS, I was able to attend the 64th conference of the Particle Therapy Cooperative Group (PTCOG). It took place from June 8-12, 2026 in Deauville, France.
  The conference covered a wide range of subjects, which gave me valuable insight into current research directly relevant to my PhD work. For instance, Relative Biological Effectiveness (RBE) and Linear Energy Transfer (LET)-based treatment planning were discussed not only for carbon ion therapy, but also for proton therapy, where an RBE of 1.1 is traditionally assumed. Several research groups presented their approaches to addressing the limitations of current RBE models, along with directions for future development. I also had productive discussions with fellow PhD candidates and senior researchers in the field.
  Beyond my current research area, the conference’s broad scope allowed me to explore topics of interest outside of my immediate field. Some sessions for example highlighted the perspectives of clinicians and medical physicists, emphasizing current challenges and innovations in their respective fields. In particular, I greatly enjoyed sessions on the practical application of radiotherapy and on clinical trials comparing different irradiation modalities, as well as studies on the cost-effectiveness of therapies for optimal resource allocation in public health.
  As my first major conference, PTCOG 64 was a wonderful experience, and I can highly recommend participation. Also, I want to thank DeGBS again for providing me with the funds necessary to partake in this conference. I can only recommend application for the DeGBS international travel grant to finance such experiences when no other funding is available.